Martin Shkreli Exits Long Valeant Pharma (VRX)/short Allergan (AGN) Trade for Loss of 3%

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. SPCX
2. NVDA
3. NFLX
4. ISRG
5. TSLA
6. META
7. RTX
8. SMCI
9. GOOGL
10. S

Go back to Martin Shkreli Exits Long Valeant Pharma (VRX)/short Allergan (AGN) Trade for Loss of 3%

Leerink PartnersRaises Price Target on Allergan (AGN) Following a MEDACorp Survey

October 28, 2015 7:05 AM EDT

Leerink Partners reiterated an Outperform rating on Allergen (NYSE: AGN), and raised the price target to $342.00 (from $311.00), following a 60 person MEDACorp survey of US plastic surgeons and dermatologists. Specialists in the survey were bullish on Kybella and expect the drug to increase their submental fat patient... More

BTIG Thinks Valeant (VRX) Should Just Severe Ties with Philidor; PT Cut to $175

October 26, 2015 2:53 PM EDT

BTIG is cutting its price target on Valeant Pharma (NYSE: VRX) from $210 down to $175, but maintaining a Buy rating following this morning's conference call.

Analyst Timothy Chiang commented, More details were provided this morning on Valeants call highlighting its relationship with Philidor,... More